<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04016857</url>
  </required_header>
  <id_info>
    <org_study_id>UMEANE1</org_study_id>
    <nct_id>NCT04016857</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning During Lower Limb Revascularization</brief_title>
  <official_title>Effects of Remote Ischemic Preconditioning on Renal Outcomes Following Lower Limb Revascularization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the role of remote ischemic preconditioning (RIPC) in
      preventing acute kidney injury after lower limb revascularization.

      Remote ischemic preconditioning(RIPC) is a simple, cost-free and non invasive procedure
      (transient upper limb ischemia/reperfusion) that could provide organ protection (Heart, Brain
      and Kidney) following ischemia injuries.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Actual">June 15, 2019</completion_date>
  <primary_completion_date type="Actual">January 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>patients were randomly assigned in 1:1 ratio to either control group or RIPC using computerized randomization table</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>The RIPC procedure were performed in the ward before going to operating room, and this is blinded to Investigators and surgical case anesthesiologist</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>AKI</measure>
    <time_frame>72h</time_frame>
    <description>the incidence of Acute Kidney Injury, defined as absolute rise of â‰¥ 0.3 mg/dL and/or a relative increase of 25% in serum creatinine compared to preoperative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AKI</measure>
    <time_frame>72h</time_frame>
    <description>the incidence of Acute Kidney Injury, defined as decrease of 35% in GFR compared to preoperative.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AKI Risk Score</measure>
    <time_frame>24h</time_frame>
    <description>the incidence of Acute Kidney Injury, defined as increase od 0.3 in Aki risk score (TIMP-2 * IGFBP-7)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Ischemic Preconditioning</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>RIPC Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remote ischemic preconditioning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham remote ischemic preconditioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RIPC</intervention_name>
    <description>4 cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of arm cuff</description>
    <arm_group_label>RIPC Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>deflated cuff placed on the left arm for 40 min</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for open limb revascularization

        Exclusion Criteria:

          -  Peripheral vascular disease affecting upper limbs

          -  Chronic kidney disease in stage 4 or 5 (eGFR&lt;30 ml/min/1,73m2)

          -  Patients underwent contrast-enhanced radiological exams in the previous 7 days

          -  Treatment with glibencamide or prostaglandins
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto Noto, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Messina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>A.O.U. G.Martino - University of Messina</name>
      <address>
        <city>Messina</city>
        <zip>98100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 8, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Alberto Noto</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>remote ischemic preconditioning</keyword>
  <keyword>lower limb revascularization</keyword>
  <keyword>TIMP-2</keyword>
  <keyword>IGFBP-7</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

